Your browser doesn't support javascript.
loading
Identifying patients with multidrug-resistant tuberculosis who may benefit from shorter durations of treatment.
Winters, Nicholas; Schnitzer, Mireille E; Campbell, Jonathon R; Ripley, Susannah; Winston, Carla; Savic, Rada; Ahmad, Nafees; Bisson, Gregory; Dheda, Keertan; Esmail, Ali; Gegia, Medea; Monedero, Ignacio; Dalcolmo, Margareth Pretti; Rodrigues, Denise; Singla, Rupak; Yim, Jae-Joon; Menzies, Dick.
Afiliação
  • Winters N; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada.
  • Schnitzer ME; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada.
  • Campbell JR; Faculty of Pharmacy, Université de Montréal, Montreal, Canada.
  • Ripley S; Department of Social and Preventive Medicine, Université de Montréal, Montreal, Canada.
  • Winston C; Department of Medicine & Department of Global and Public Health, Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.
  • Savic R; McGill International TB Centre, Montreal Chest Institute, Research Institute of the McGill University Health Centre, Montreal, Canada.
  • Ahmad N; Respiratory Epidemiology and Clinical Research Unit, Centre for Outcomes Research & Evaluation, Research Institute of the McGill University Health Centre, Montreal, Canada.
  • Bisson G; Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Canada.
  • Dheda K; US Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
  • Esmail A; Department of Bioengineering and Therapeutic Sciences, University of California San Francisco Schools of Pharmacy and Medicine, San Francisco, California, United States of America.
  • Gegia M; UCSF Center for Tuberculosis, University of California San Francisco, San Francisco, California, United States of America.
  • Monedero I; Faculty of Pharmacy and Health Sciences, University of Baluchistan, Quetta, Pakistan.
  • Dalcolmo MP; Department of Medicine and Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States of America.
  • Rodrigues D; Centre for Lung Infection and Immunity, Department of Medicine & UCT Lung Institute, University of Cape Town, Cape Town, South Africa.
  • Singla R; Centre for Lung Infection and Immunity, Department of Medicine & UCT Lung Institute, University of Cape Town, Cape Town, South Africa.
  • Yim JJ; Global Tuberculosis Program, World Health Organization, Geneva, Switzerland.
  • Menzies D; TB-HIV Department, International Union against Tuberculosis and Lung Diseases, Paris, France.
PLoS One ; 18(10): e0292106, 2023.
Article em En | MEDLINE | ID: mdl-37797071
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 3_ND Problema de saúde: 2_enfermedades_transmissibles / 3_neglected_diseases / 3_tuberculosis Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos Tipo de estudo: Observational_studies / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 3_ND Problema de saúde: 2_enfermedades_transmissibles / 3_neglected_diseases / 3_tuberculosis Assunto principal: Tuberculose Resistente a Múltiplos Medicamentos Tipo de estudo: Observational_studies / Prognostic_studies / Systematic_reviews Limite: Humans Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá